Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
2(50%)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_1
1
25%
Ph phase_2
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
33.3%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
N/A2 (50.0%)

Trials by Status

recruiting125%
completed125%
terminated250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

NCT06882993
terminatednot_applicable

PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study

NCT04274010
completedphase_1

PillCam® Platform With the PillCam Crohn's Disease Capsule

NCT01631435
terminatedphase_2

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

NCT02247258

Clinical Trials (4)

Showing 4 of 4 trials
NCT06882993Not Applicable

Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

Recruiting
NCT04274010Not Applicable

PANenteric Crohn's Capsule Versus Ileo-Colonoscopy and Scan Study

Terminated
NCT01631435Phase 1

PillCam® Platform With the PillCam Crohn's Disease Capsule

Completed
NCT02247258Phase 2

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4